[DOI] [PMC free article] [PubMed] [Google Scholar] 20.Stanke-Labesque F., Gautier-Veyret E., Chhun S., Guilhaumou R., French Society of Pharmacology and Therapeutics Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment
J Biol Chem 280 , 3376633774, doi: 10.1074/jbc.M504604200 (2005)
Autoimmune disorders are conditions like celiac disease and Crohns disease, which are associated with disruptions in intestinal permeability, potentially worsening immune system dysfunction
513,514 Astrocytes from FMR1 knockout mouse model of fragile X syndrome were characterised by an enhanced secretion pf interleukin-6 and tenascin C, as well as by increased purinergic signalling
Vigorous shaking of reconstituted peptide vials represents one of the most common mistakes that can render BPC-157 inactive